BindingDB logo
myBDB logout

BDBM50523598 CHEMBL4530290

SMILES: OC(=O)C[C@H]1CC[C@H](CC1)Oc1ccc(cn1)-c1ccc(cn1)-c1nc2cc(cnc2[nH]1)C(F)(F)F

InChI Key: InChIKey=UNWXUCUCEFLFIK-UJKQEGAGSA-N

Data: 1 KI  4 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 5 hits for monomerid = 50523598   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
1,3-beta-glucan synthase component GLS2


(Saccharomyces cerevisiae)
BDBM50523598
PNG
(CHEMBL4530290)
Show SMILES OC(=O)C[C@H]1CC[C@H](CC1)Oc1ccc(cn1)-c1ccc(cn1)-c1nc2cc(cnc2[nH]1)C(F)(F)F |r,wD:7.10,4.3,(46.61,-28,;45.84,-26.67,;44.3,-26.66,;46.62,-25.34,;45.85,-24,;46.62,-22.67,;45.85,-21.33,;44.32,-21.34,;43.54,-22.67,;44.31,-23.99,;43.55,-20.01,;42.01,-20.01,;41.23,-18.67,;39.69,-18.68,;38.93,-20.01,;39.7,-21.34,;41.23,-21.34,;37.39,-20.01,;36.61,-18.67,;35.08,-18.67,;34.31,-20,;35.08,-21.34,;36.62,-21.34,;32.78,-20,;31.87,-18.75,;30.4,-19.23,;29.06,-18.46,;27.73,-19.23,;27.73,-20.78,;29.07,-21.55,;30.4,-20.77,;31.87,-21.25,;26.4,-18.47,;26.4,-16.93,;25.07,-19.24,;25.06,-17.69,)|
Show InChI InChI=1S/C25H22F3N5O3/c26-25(27,28)17-10-20-24(31-13-17)33-23(32-20)16-3-7-19(29-12-16)15-4-8-21(30-11-15)36-18-5-1-14(2-6-18)9-22(34)35/h3-4,7-8,10-14,18H,1-2,5-6,9H2,(H,34,35)(H,31,32,33)/t14-,18+
KEGG

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
2.34E+4n/an/an/an/an/an/an/an/a



Merck & Co. Inc

Curated by ChEMBL


Assay Description
Inhibition of human ERG


Bioorg Med Chem Lett 29: 1380-1385 (2019)


Article DOI: 10.1016/j.bmcl.2019.03.039
More data for this
Ligand-Target Pair
Diacylglycerol O-acyltransferase 1


(Mus musculus (mouse))
BDBM50523598
PNG
(CHEMBL4530290)
Show SMILES OC(=O)C[C@H]1CC[C@H](CC1)Oc1ccc(cn1)-c1ccc(cn1)-c1nc2cc(cnc2[nH]1)C(F)(F)F |r,wD:7.10,4.3,(46.61,-28,;45.84,-26.67,;44.3,-26.66,;46.62,-25.34,;45.85,-24,;46.62,-22.67,;45.85,-21.33,;44.32,-21.34,;43.54,-22.67,;44.31,-23.99,;43.55,-20.01,;42.01,-20.01,;41.23,-18.67,;39.69,-18.68,;38.93,-20.01,;39.7,-21.34,;41.23,-21.34,;37.39,-20.01,;36.61,-18.67,;35.08,-18.67,;34.31,-20,;35.08,-21.34,;36.62,-21.34,;32.78,-20,;31.87,-18.75,;30.4,-19.23,;29.06,-18.46,;27.73,-19.23,;27.73,-20.78,;29.07,-21.55,;30.4,-20.77,;31.87,-21.25,;26.4,-18.47,;26.4,-16.93,;25.07,-19.24,;25.06,-17.69,)|
Show InChI InChI=1S/C25H22F3N5O3/c26-25(27,28)17-10-20-24(31-13-17)33-23(32-20)16-3-7-19(29-12-16)15-4-8-21(30-11-15)36-18-5-1-14(2-6-18)9-22(34)35/h3-4,7-8,10-14,18H,1-2,5-6,9H2,(H,34,35)(H,31,32,33)/t14-,18+
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 9.5n/an/an/an/an/an/a



Merck & Co. Inc

Curated by ChEMBL


Assay Description
Inhibition of mouse DGAT1


Bioorg Med Chem Lett 29: 1380-1385 (2019)


Article DOI: 10.1016/j.bmcl.2019.03.039
More data for this
Ligand-Target Pair
Sterol O-acyltransferase 1


(Homo sapiens (Human))
BDBM50523598
PNG
(CHEMBL4530290)
Show SMILES OC(=O)C[C@H]1CC[C@H](CC1)Oc1ccc(cn1)-c1ccc(cn1)-c1nc2cc(cnc2[nH]1)C(F)(F)F |r,wD:7.10,4.3,(46.61,-28,;45.84,-26.67,;44.3,-26.66,;46.62,-25.34,;45.85,-24,;46.62,-22.67,;45.85,-21.33,;44.32,-21.34,;43.54,-22.67,;44.31,-23.99,;43.55,-20.01,;42.01,-20.01,;41.23,-18.67,;39.69,-18.68,;38.93,-20.01,;39.7,-21.34,;41.23,-21.34,;37.39,-20.01,;36.61,-18.67,;35.08,-18.67,;34.31,-20,;35.08,-21.34,;36.62,-21.34,;32.78,-20,;31.87,-18.75,;30.4,-19.23,;29.06,-18.46,;27.73,-19.23,;27.73,-20.78,;29.07,-21.55,;30.4,-20.77,;31.87,-21.25,;26.4,-18.47,;26.4,-16.93,;25.07,-19.24,;25.06,-17.69,)|
Show InChI InChI=1S/C25H22F3N5O3/c26-25(27,28)17-10-20-24(31-13-17)33-23(32-20)16-3-7-19(29-12-16)15-4-8-21(30-11-15)36-18-5-1-14(2-6-18)9-22(34)35/h3-4,7-8,10-14,18H,1-2,5-6,9H2,(H,34,35)(H,31,32,33)/t14-,18+
PDB

KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a>2.00E+3n/an/an/an/an/an/a



Merck & Co. Inc

Curated by ChEMBL


Assay Description
Inhibition of human ACAT1


Bioorg Med Chem Lett 29: 1380-1385 (2019)


Article DOI: 10.1016/j.bmcl.2019.03.039
More data for this
Ligand-Target Pair
Diacylglycerol O-acyltransferase 1


(Homo sapiens (Human))
BDBM50523598
PNG
(CHEMBL4530290)
Show SMILES OC(=O)C[C@H]1CC[C@H](CC1)Oc1ccc(cn1)-c1ccc(cn1)-c1nc2cc(cnc2[nH]1)C(F)(F)F |r,wD:7.10,4.3,(46.61,-28,;45.84,-26.67,;44.3,-26.66,;46.62,-25.34,;45.85,-24,;46.62,-22.67,;45.85,-21.33,;44.32,-21.34,;43.54,-22.67,;44.31,-23.99,;43.55,-20.01,;42.01,-20.01,;41.23,-18.67,;39.69,-18.68,;38.93,-20.01,;39.7,-21.34,;41.23,-21.34,;37.39,-20.01,;36.61,-18.67,;35.08,-18.67,;34.31,-20,;35.08,-21.34,;36.62,-21.34,;32.78,-20,;31.87,-18.75,;30.4,-19.23,;29.06,-18.46,;27.73,-19.23,;27.73,-20.78,;29.07,-21.55,;30.4,-20.77,;31.87,-21.25,;26.4,-18.47,;26.4,-16.93,;25.07,-19.24,;25.06,-17.69,)|
Show InChI InChI=1S/C25H22F3N5O3/c26-25(27,28)17-10-20-24(31-13-17)33-23(32-20)16-3-7-19(29-12-16)15-4-8-21(30-11-15)36-18-5-1-14(2-6-18)9-22(34)35/h3-4,7-8,10-14,18H,1-2,5-6,9H2,(H,34,35)(H,31,32,33)/t14-,18+
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 7n/an/an/an/an/an/a



Merck & Co. Inc

Curated by ChEMBL


Assay Description
Inhibition of human DGAT1


Bioorg Med Chem Lett 29: 1380-1385 (2019)


Article DOI: 10.1016/j.bmcl.2019.03.039
More data for this
Ligand-Target Pair
Adenosine receptor A2a


(Homo sapiens (Human))
BDBM50523598
PNG
(CHEMBL4530290)
Show SMILES OC(=O)C[C@H]1CC[C@H](CC1)Oc1ccc(cn1)-c1ccc(cn1)-c1nc2cc(cnc2[nH]1)C(F)(F)F |r,wD:7.10,4.3,(46.61,-28,;45.84,-26.67,;44.3,-26.66,;46.62,-25.34,;45.85,-24,;46.62,-22.67,;45.85,-21.33,;44.32,-21.34,;43.54,-22.67,;44.31,-23.99,;43.55,-20.01,;42.01,-20.01,;41.23,-18.67,;39.69,-18.68,;38.93,-20.01,;39.7,-21.34,;41.23,-21.34,;37.39,-20.01,;36.61,-18.67,;35.08,-18.67,;34.31,-20,;35.08,-21.34,;36.62,-21.34,;32.78,-20,;31.87,-18.75,;30.4,-19.23,;29.06,-18.46,;27.73,-19.23,;27.73,-20.78,;29.07,-21.55,;30.4,-20.77,;31.87,-21.25,;26.4,-18.47,;26.4,-16.93,;25.07,-19.24,;25.06,-17.69,)|
Show InChI InChI=1S/C25H22F3N5O3/c26-25(27,28)17-10-20-24(31-13-17)33-23(32-20)16-3-7-19(29-12-16)15-4-8-21(30-11-15)36-18-5-1-14(2-6-18)9-22(34)35/h3-4,7-8,10-14,18H,1-2,5-6,9H2,(H,34,35)(H,31,32,33)/t14-,18+
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 970n/an/an/an/an/an/a



Merck & Co. Inc

Curated by ChEMBL


Assay Description
Activity against human A2AR assessed as inhibition of cAMP accumulation by cAMP functional assay


Bioorg Med Chem Lett 29: 1380-1385 (2019)


Article DOI: 10.1016/j.bmcl.2019.03.039
More data for this
Ligand-Target Pair